Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream while Breastfeeding
Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream while breast-feeding.

What is the use of Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream ?

Sunscreen Sunscreen

Can I use Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream while breastfeeding?

Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream high risk while breastfeeding
Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream consists two active ingredients Octinoxate and Titanium dioxide and as per our analysis of both we have determined the Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream in breastfeeding.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.


I am nursing mother and I have already used Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream, what should I do?

We have already established that Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream is unsafe in breastfeeding and breastfeeding while using Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My doctor has prescribed me Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream then there must be good reason for that as Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Face It Power Perfection 32800312 | Octinoxate And Titanium Dioxide Cream Cream in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients